{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:48:23Z","timestamp":1773881303080,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.anndiagpath.2019.04.015","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T17:45:06Z","timestamp":1557337506000},"page":"14-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Magnifying glass on spiradenoma and cylindroma histogenesis and tumorigenesis using systematic transcriptome analysis"],"prefix":"10.1016","volume":"41","author":[{"given":"Achim H.","family":"Bell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor G.","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Ferrarotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan P.","family":"Goepfert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey N.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randal","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2019.04.015_bb0005","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/ajcp\/35.6.504","article-title":"Dermal cylindroma (dermal eccrine cylindroma)","volume":"35","author":"Crain","year":"1961","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2019.04.015_bb0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archderm.1956.01550030001001","article-title":"Eccrine spiradenoma","volume":"73","author":"Kersting","year":"1956","journal-title":"AMA Arch Derm"},{"key":"10.1016\/j.anndiagpath.2019.04.015_bb0015","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/archderm.1963.01590240204034","article-title":"Dermal eccrine cylindroma: a histochemical, electron microscopic, and therapeutic (X-ray) study","volume":"88","author":"Urbach","year":"1963","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.04.015_bb0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/jcp.2006.040337","article-title":"Skin adnexal neoplasms\u2013part 1: an approach to tumours of the pilosebaceous unit","volume":"60","author":"Alsaad","year":"2007","journal-title":"J Clin Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.04.015_bb0025","doi-asserted-by":"crossref","first-page":"xi","DOI":"10.1016\/j.path.2017.03.001","article-title":"Diagnostic challenges in dermatopathology","volume":"10","author":"Brenn","year":"2017","journal-title":"Surg Pathol Clin"},{"issue":"5","key":"10.1016\/j.anndiagpath.2019.04.015_bb0030","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-0560.1983.tb00333.x","article-title":"Eccrine spiradenoma: clinical and pathologic study of 49 tumors","volume":"10","author":"Mambo","year":"1983","journal-title":"J Cutan Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.04.015_bb0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/jcp.2006.041608","article-title":"Skin adnexal neoplasms\u2013part 2: an approach to tumours of cutaneous sweat glands","volume":"60","author":"Obaidat","year":"2007","journal-title":"J Clin Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.04.015_bb0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12105-016-0705-x","article-title":"Brooke-Spiegler syndrome and phenotypic variants: an update","volume":"10","author":"Kazakov","year":"2016","journal-title":"Head Neck Pathol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2019.04.015_bb0045","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/PAS.0b013e3181966762","article-title":"Morphologic diversity of malignant neoplasms arising in preexisting spiradenoma, cylindroma, and spiradenocylindroma based on the study of 24 cases, sporadic or occurring in the setting of Brooke-Spiegler syndrome","volume":"33","author":"Kazakov","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.04.015_bb0050","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.path.2017.01.010","article-title":"Update on malignant sweat gland tumors","volume":"10","author":"van der Horst","year":"2017","journal-title":"Surg Pathol Clin"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.04.015_bb0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/PDM.0b013e3181ba2d96","article-title":"Brooke-Spiegler syndrome: report of 10 patients from 8 families with novel germline mutations: evidence of diverse somatic mutations in the same patient regardless of tumor type","volume":"19","author":"Sima","year":"2010","journal-title":"Diagn Mol Pathol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2019.04.015_bb0060","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.amjsurg.2010.04.015","article-title":"Malignant eccrine spiradenoma: a meta-analysis of reported cases","volume":"201","author":"Andreoli","year":"2011","journal-title":"Am J Surg"},{"issue":"3","key":"10.1016\/j.anndiagpath.2019.04.015_bb0065","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.annder.2016.09.038","article-title":"Malignant transformation of an eccrine spiradenoma","volume":"144","author":"Jacquemus","year":"2017","journal-title":"Ann Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2019.04.015_bb0070","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/jcp.50.10.871","article-title":"Malignant eccrine spiradenoma with carcinomatous and sarcomatous elements","volume":"50","author":"McCluggage","year":"1997","journal-title":"J Clin Pathol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2019.04.015_bb0075","doi-asserted-by":"crossref","first-page":"591","DOI":"10.5858\/2002-126-0591-MES","article-title":"Malignant eccrine spiradenoma","volume":"126","author":"Mirza","year":"2002","journal-title":"Arch Pathol Lab Med"},{"issue":"7","key":"10.1016\/j.anndiagpath.2019.04.015_bb0080","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/modpathol.2015.48","article-title":"Morphologically low-grade spiradenocarcinoma: a clinicopathologic study of 19 cases with emphasis on outcome and MYB expression","volume":"28","author":"van der Horst","year":"2015","journal-title":"Mod Pathol"},{"issue":"Suppl. 2","key":"10.1016\/j.anndiagpath.2019.04.015_bb0085","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1038\/modpathol.3800511","article-title":"Malignant adnexal neoplasms","volume":"19","author":"Crowson","year":"2006","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2019.04.015_bb0090","first-page":"37","article-title":"On malignant transformation of eccrine spiradenoma","volume":"21","author":"Dabska","year":"1971","journal-title":"Nowotwory"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.04.015_bb0095","first-page":"388","volume":"11","year":"1972","journal-title":"Pol Med J"},{"issue":"7","key":"10.1016\/j.anndiagpath.2019.04.015_bb0100","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/DAD.0b013e3181a1573e","article-title":"Adenoid cystic carcinoma-like pattern in spiradenoma and spiradenocylindroma: a rare feature in sporadic neoplasms and those associated with Brooke-Spiegler syndrome","volume":"31","author":"Petersson","year":"2009","journal-title":"Am J Dermatopathol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2019.04.015_bb0105","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/cncr.29959","article-title":"In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type","volume":"122","author":"Bell","year":"2016","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.anndiagpath.2019.04.015_bb0110","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00000372-200608000-00010","article-title":"Low-grade adnexal carcinoma of the skin with multidirectional (glandular, trichoblastomatous, spiradenocylindromatous) differentiation","volume":"28","author":"Kazakov","year":"2006","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.anndiagpath.2019.04.015_bb0115","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/jid.1962.157","article-title":"Ultrastructure and histochemical characteristics of dermal eccrine cylindroma (turban tumor)","volume":"39","author":"Munger","year":"1962","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.04.015_bb0120","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/cup.12406","article-title":"Spiradenoma and cylindroma originate from the hair follicle bulge and not from the eccrine sweat gland: an immunohistochemical study with CD200 and other stem cell markers","volume":"42","author":"Sellheyer","year":"2015","journal-title":"J Cutan Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.04.015_bb0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/jid.1967.121","article-title":"Histochemistry of hidradenoma and eccrine spiradenoma","volume":"49","author":"Winkelmann","year":"1967","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.anndiagpath.2019.04.015_bb0130","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1471-2407-13-227","article-title":"Odontogenic ameloblast-associated protein (ODAM) inhibits growth and migration of human melanoma cells and elicits PTEN elevation and inactivation of PI3K\/AKT signaling","volume":"13","author":"Foster","year":"2013","journal-title":"BMC Cancer"},{"issue":"3\u20134","key":"10.1016\/j.anndiagpath.2019.04.015_bb0135","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.gep.2012.02.002","article-title":"Expression pattern, subcellular localization, and functional implications of ODAM in ameloblasts, odontoblasts, osteoblasts, and various cancer cells","volume":"12","author":"Lee","year":"2012","journal-title":"Gene Expr Patterns"},{"issue":"7","key":"10.1016\/j.anndiagpath.2019.04.015_bb0140","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/cbf.3132","article-title":"ODAM inhibits RhoA-dependent invasion in breast cancer","volume":"33","author":"Lee","year":"2015","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.anndiagpath.2019.04.015_bb0145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4137\/BCBCR.S6859","article-title":"ODAM expression inhibits human breast cancer tumorigenesis","volume":"5","author":"Kestler","year":"2011","journal-title":"Breast Cancer (Auckl)"},{"issue":"5","key":"10.1016\/j.anndiagpath.2019.04.015_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064223","article-title":"Highly upregulated Lhx2 in the Foxn1\u2212\/\u2212 nude mouse phenotype reflects a dysregulated and expanded epidermal stem cell niche","volume":"8","author":"Bohr","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.04.015_bb0155","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008029","article-title":"Wnt signaling in skin development, homeostasis, and disease","volume":"5","author":"Lim","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"28","key":"10.1016\/j.anndiagpath.2019.04.015_bb0160","doi-asserted-by":"crossref","first-page":"24596","DOI":"10.18632\/oncotarget.5237","article-title":"Progenitor cell fate, SOXC and WNT","volume":"6","author":"Bhattaram","year":"2015","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.anndiagpath.2019.04.015_bb0165","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/onc.2014.44","article-title":"High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma","volume":"34","author":"Kuo","year":"2015","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.anndiagpath.2019.04.015_bb0170","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/cncy.21465","article-title":"The role of SOX11 immunostaining in confirming the diagnosis of mantle cell lymphoma on fine-needle aspiration samples","volume":"122","author":"Zhang","year":"2014","journal-title":"Cancer Cytopathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2019.04.015_bb0175","first-page":"1","article-title":"Caught up in a Wnt storm: Wnt signaling in cancer","volume":"1653","author":"Giles","year":"2003","journal-title":"Biochim Biophys Acta"},{"issue":"Pt 3","key":"10.1016\/j.anndiagpath.2019.04.015_bb0180","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1242\/jcs.03363","article-title":"Wnt signalling: variety at the core","volume":"120","author":"Hoppler","year":"2007","journal-title":"J Cell Sci"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.04.015_bb0185","doi-asserted-by":"crossref","first-page":"VIII","DOI":"10.1111\/j.0022-202X.2004.23239.x","article-title":"Regulating the regulators: routing the Wnt-beta-catenin\u2013Lef signals","volume":"123","author":"Widelitz","year":"2004","journal-title":"J Invest Dermatol"},{"issue":"13","key":"10.1016\/j.anndiagpath.2019.04.015_bb0190","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1101\/gad.891401","article-title":"Tcf3 and Lef1 regulate lineage differentiation of multipotent stem cells in skin","volume":"15","author":"Merrill","year":"2001","journal-title":"Genes Dev"},{"issue":"7","key":"10.1016\/j.anndiagpath.2019.04.015_bb0195","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1158\/0008-5472.CAN-06-3427","article-title":"Dual role of inactivating Lef1 mutations in epidermis: tumor promotion and specification of tumor type","volume":"67","author":"Niemann","year":"2007","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.anndiagpath.2019.04.015_bb0200","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1365-2133.2009.09144.x","article-title":"LEF-1 expression in basal cell carcinomas","volume":"160","author":"Kriegl","year":"2009","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2019.04.015_bb0205","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1210\/me.2010-0513","article-title":"LEF1 identifies androgen-independent epithelium in the developing prostate","volume":"25","author":"Wu","year":"2011","journal-title":"Mol Endocrinol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2019.04.015_bb0210","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.3892\/ol.2016.4901","article-title":"The function of homeobox genes and lncRNAs in cancer","volume":"12","author":"Wang","year":"2016","journal-title":"Oncol Lett"},{"issue":"4","key":"10.1016\/j.anndiagpath.2019.04.015_bb0215","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.3892\/mmr.2015.4161","article-title":"Long non-coding RNA HOTAIR: a novel oncogene (review)","volume":"12","author":"Yu","year":"2015","journal-title":"Mol Med Rep"},{"issue":"5","key":"10.1016\/j.anndiagpath.2019.04.015_bb0220","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/cup.12904","article-title":"MYB, CD117 and SOX-10 expression in cutaneous adnexal tumors","volume":"44","author":"Evangelista","year":"2017","journal-title":"J Cutan Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.04.015_bb0225","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/path.4717","article-title":"Overexpression of MYB drives proliferation of CYLD-defective cylindroma cells","volume":"239","author":"Rajan","year":"2016","journal-title":"J Pathol"},{"issue":"13","key":"10.1016\/j.anndiagpath.2019.04.015_bb0230","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1002\/cncr.25818","article-title":"CpG island methylation profiling in human salivary gland adenoid cystic carcinoma","volume":"117","author":"Bell","year":"2011","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.anndiagpath.2019.04.015_bb0235","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/cncr.26412","article-title":"Developmental transcription factor EN1\u2013a novel biomarker in human salivary gland adenoid cystic carcinoma","volume":"118","author":"Bell","year":"2012","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.anndiagpath.2019.04.015_bb0240","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/his.13486","article-title":"Homeobox transcriptional factor engrailed homeobox 1 is expressed specifically in normal and neoplastic sweat gland cells","volume":"72","author":"Miura","year":"2018","journal-title":"Histopathology"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913419301236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913419301236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:30:25Z","timestamp":1761078625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913419301236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":48,"alternative-id":["S1092913419301236"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2019.04.015","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Magnifying glass on spiradenoma and cylindroma histogenesis and tumorigenesis using systematic transcriptome analysis","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2019.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}